Christopher Bethel Yesterday, the AP claimed the DEA might be reclassifying marijuana from the agenda I (within a classification with heroin and lsd, i.e. a drug with no now approved clinical use and higher opportunity for abuse) to some Schedule III drug (in a class with ketamine and anabolic steroids). This is crucial - even though it continues t… Read More